Academic pharmacist Nataly Martini discusses the medical management of asthma in adults and adolescents, which has evolved to prioritise early anti-inflammatory treatment. She also explains how to improve patient outcomes by proactively identifying poor asthma control and supporting equitable access to education and treatment
The hype versus the evidence relating to cannabinoids
Tuesday 1 December 2020, 01:30 AM

There is a lack of good-quality evidence for therapeutic benefits of cannabinoids from the cannabis plant. Photo: Kym Mackinnon on Unsplash
Results from the cannabis referendum showed that, as a nation, we are not ready to legalise cannabis. However, patients with a variety of problems ask to be prescribed medicinal cannabis. Psychiatrist David Codyre, reviews the evidence for both benefits and harms of cannabinoids
The endocannabinoid system is present in all animal species, and it is ancient – the system has played an important biological role for hundreds of m, Cannabinoids key points
Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā
Not a subscriber? Unlock this article by subscribing here.
References
- Elphick MR. The evolution and comparative neurobiology of endocannabinoid signalling. Philos Trans R Soc Lond B Biol Sci 2012;367(1607):3201–15.
- National Academies of Sciences, Engineering and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017.
- Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 2005;57(10):1117–27.
- Lowe DJE, Sasiadek JD, Coles AS, et al. Cannabis and mental illness: a review. Eur Arch Psychiatry Clin Neurosci 2019;269(1):107–20.